Tscan therapeutics announces fda clearance of investigational new drug application for tsc-101 for the treatment of hematologic malignancies

Study start-up activities now ongoing for all three arms of the phase 1 umbrella trial of tsc-100 and tsc-101 study start-up activities now ongoing for all three arms of the phase 1 umbrella trial of tsc-100 and tsc-101

TCRX Ratings Summary

TCRX Quant Ranking